Back to Clinical Research

TG-MV-014

Status: Completed

ClinicalTrials.gov Identifier: NCT01429441

TG-MV-014: Study of Ocriplasmin in patients with symptomatic vitreomacular adhesion/(VMT) including macular hole.

Condition:

• Vitreomacular Adhesion including Macular Hole

Study Type: Interventional

Duration: 3 years

Eligibility:

• Ages: 18 years and older
• Sexes: All
• Accepts Healthy Volunteers: No

For more information on this study, please click here

Back to Clinical Research